Vincerx Pharma Inc.

NASDAQ: VINC · Real-Time Price · USD
0.05
-0.00 (-1.96%)
At close: Jun 09, 2025, 12:40 PM

Vincerx Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
4.99M 12.78M 11.66M 111.46M
Short-Term Investments
n/a n/a 40.8M n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
1.59M 1.16M 81K 1.65M
Receivables
1.04M 1.04M 1.37M n/a
Inventory
n/a n/a -1.24M n/a
Other Current Assets
128K 1.9M 439K 200K
Total Current Assets
6.41M 14.73M 55.96M 111.84M
Property-Plant & Equipment
n/a 2.33M 3.24M 4.18M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
1.59M 3.48M 3.32M 5.83M
Total Assets
8.01M 18.22M 59.29M 117.68M
Account Payables
2.03M 2.5M 4.07M 2.02M
Deferred Revenue
n/a n/a n/a 4.71M
Short-Term Debt
n/a n/a 1.02M 738K
Other Current Liabilities
8K 191K 1.16M 8.22M
Total Current Liabilities
5.28M 5.61M 9.16M 13.92M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a 50K 50K n/a
Total Long-Term Liabilities
n/a 1.39M 2.46M 3.44M
Total Liabilities
5.28M 7M 11.62M 17.36M
Total Debt
n/a 2.5M 3.44M 4.17M
Common Stock
n/a 2K 2K 2K
Retained Earnings
-189.19M -159.11M -121.34M -55.97M
Comprehensive Income
119K 8K -26K -21K
Shareholders Equity
2.72M 11.22M 47.67M 100.32M
Total Investments
n/a n/a 40.8M n/a